23rd Annual Biotech & Pharmaceutical Patenting 2015

Topics

• Patenting genes and theranostics including HGS v Lilly
• Developments in European patent law in the last 12 months
• Product launch strategies and preliminary injunctions including the Solvay case
• Dealing with competition law issues in patenting
• The Unified Patent Court – what will the impact be?
• Planning for patent expiry and managing innovation
• Strategies for maximising patent life cycles - exploring the application of SPCs to extend patents
• SPCs masterclass - recent case law and varying requirements around Europe including an analysis of the impact of Neurim

Who should Attend

• Patent Attorneys and Agents
• Biotech and Pharma Companies: In-house Counsel, Patent Attorneys, IP Managers, Legal Advisors, Patent Advisors, Chief IP Counsel, IP Directors, Scientific Researchers, CEOs and Corporate Management
• Intellectual Property Consultants
• Intellectual Property Lawyers
• Academics
• Examiners